MSN's Generic Ziprasidone Mesylate Receives Approval in the U.S.
Hyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the launch of Ziprasidone Mesylate for Injection, 20 mg (base)/mL Single-dose Vials, the therapeutic generic equivalent of Geodon® (ziprasidone mesylate) Injection, 20 mg/mL, approved by the U.S. Food and Drug Administration (USFDA).
Pharma major Dr Reddy’s Laboratories Ltd has launched Ziprasidone Mesylate for injection. The product is the therapeutic generic equivalent of Geodon (Ziprasidone Mesylate) injection approved by the US Food and Drug Administration (USFDA). Geodon is a trademark of Pfizer.s
Gland Pharma`s Generic Ziprasidone Mesylate Receives Approval in US
Market Place
Share Share
Share Share
